Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anaptysbio Inc (ANAB)

Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anaptysbio Inc 10770 WATERIDGE CIRCLE SUITE 210 SAN DIEGO CA 92121 USA

www.anaptysbio.com P: 858-362-6295 F: 858-362-6296

Description:

AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 1,024,463
Enterprise Value, $K 988,493
Shares Outstanding, K 27,319
Annual Sales, $ 17,160 K
Annual Net Income, $ -163,620 K
Last Quarter Sales, $ 10,970 K
Last Quarter Net Income, $ -46,660 K
EBIT, $ -155,050 K
EBITDA, $ -163,200 K
60-Month Beta -0.29
% of Insider Shareholders 33.70%
Float, K 18,112
% Float 66.30%
Short Volume Ratio 0.50

Growth:

1-Year Return 89.78%
3-Year Return 33.76%
5-Year Return 3.77%
5-Year Revenue Growth 243.20%
5-Year Earnings Growth -143.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.71 on 08/05/24
Next Earnings Date 11/07/24
Earnings Per Share ttm -6.35
EPS Growth vs. Prev Qtr -4.27%
EPS Growth vs. Prev Year -14.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ANAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -255.67%
Return-on-Assets % -38.38%
Profit Margin % -953.50%
Debt/Equity 0.00
Price/Sales 61.91
Price/Cash Flow N/A
Price/Book 112.00
Book Value/Share 0.36
Interest Coverage -2.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar